Injective slides as bears maintain short-term momentum within $5.24–$5.78 range

Injective slides as bears maintain short-term momentum within $5.24–$5.78 range
Injective slides 7.13% to $5.51 today

Injective (INJ) is trading at $5.51, marking a decline of 7.13% on the day. The asset is now positioned below its key short- and medium-term moving averages but remains above its longer-term trend level.

INJ price prediction
24H 0.19%
$5.41
48H 2.59%
$5.54
7D 6.48%
$5.75
1M 5.56%
$5.7
3M 148.89%
$13.44
6M 116.85%
$11.71
12M 96.11%
$10.59
Current price: $ 5.4 -0.5 8.41%
Real-time Data 09:58
Daily range 5.41 Arrow from to Icon 5.71
Weekly range 4.92 Arrow from to Icon 6.11
Loading...

Highlights

  • Injective (INJ/USD) faces sustained bearish pressure, trading below key short- and medium-term moving averages on the hourly chart.
  • Momentum indicators signal strong downside amid high volatility, though oversold readings raise short-term mean reversion risk.
  • Expected trading range for the next 2–3 days is $5.24 to $5.78, with immediate bias toward further consolidation or downside.

Bearish momentum confirmed as support holds but trend conviction falters

On the hourly chart, INJ trades below the MA-20 and MA-50, while remaining above the MA-200, highlighting the $5.51 area as key short-term support. The Ichimoku Kijun level at $5.81 serves as immediate resistance. MACD and Awesome Oscillator confirm current bearish momentum, while ADX remains neutral, suggesting the move lacks strong trend conviction. The RSI is in the sell zone, and both CCI and Stoch RSI show oversold conditions, signaling an oversold state without a clear reversal signal. The Bull/Bear Power (BBP) indicates intraday dominance by sellers.

Injective asset chart
Injective price dynamics. Source: TradingView.

Downward bias expected as volatility maintains tight trading range

Looking ahead over the next 23 sessions, the expected price range is $5.24 to $5.78, reflecting typical volatility. There is a 30% probability for an upward move, with a more likely scenario of continued downward bias or consolidation between visible support and resistance levels. A move above $5.81 would be required to improve the short-term outlook, while a break below $5.24 may open the way for further downside.

Anton Kharitonov, expert at Traders Union, sees continued weakness in Injective as the asset trades below its short- and medium-term moving averages and intraday signals remain bearish. He notes that oversold readings from the CCI and Stoch RSI are not yet producing a clear reversal. Until $5.81 is reclaimed, the setup favors either more downside or sideways trading. "I remain defensive on INJ — as long as price stays below $5.81, I see little reason to get involved."

Earlier, analysts noted that Injective's outlook was constructive, supported by ongoing ecosystem developments and positive longer-term momentum. The recent shift to short-term bearish momentum and a loss of key moving average support signals increased caution, making the $5.24 support level critical for traders monitoring downside risk in the coming sessions.

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.